(Q38802995)

6 September 2017

title

Proteomics as an innovative tool to investigate frontotemporal disorders (English)

1 reference

6 September 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27061321%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Antonella De Palma

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27061321%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Pietroluigi Mauri

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27061321%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

5

Paolo Iadarola

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27061321%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

author name string

Anna Bardoni

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27061321%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Roberta Salvini

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27061321%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

publication date

10 December 2015

1 reference

Proteomics - Clinical Applications

6 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27061321%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27061321%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27061321%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

page(s)

457-469

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27061321%20AND%20SRC:MED&resulttype=core&format=json

Tale of two diseases: amyotrophic lateral sclerosis and frontotemporal dementia

3 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

Progress in unraveling the genetic etiology of Parkinson disease in a genomic era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

Retromer in Alzheimer disease, Parkinson disease and other neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

Genes and mechanisms involved in beta-amyloid generation and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

Genetic heterogeneity in Alzheimer disease and implications for treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

Alzheimer's disease and amyloid: culprit or coincidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

Dispersible amyloid β-protein oligomers, protofibrils, and fibrils represent diffusible but not soluble aggregates: their role in neurodegeneration in amyloid precursor protein (APP) transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

alpha-Synuclein locus triplication causes Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

Alpha-synuclein locus duplication as a cause of familial Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

Diagnosis and management of behavioral variant frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

Differentiating frontal and temporal variant frontotemporal dementia from Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

Frontotemporal lobar degeneration: a clinical approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

More evidence for association of a rare TREM2 mutation (R47H) with Alzheimer's disease risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

TREM2 is associated with increased risk for Alzheimer's disease in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

Homozygous TREM2 mutation in a family with atypical frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

Disease-Associated Mutations of TREM2 Alter the Processing of N-Linked Oligosaccharides in the Golgi Apparatus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

Nasu-Hakola disease (polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy--PLOSL): a dementia associated with bone cystic lesions. From clinical to genetic and molecular aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

Imaging frontotemporal lobar degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

Histopathological changes underlying frontotemporal lobar degeneration with clinicopathological correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

Frontotemporal dementia: from Mendelian genetics towards genome wide association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

Cerebrospinal fluid proteomics and protein biomarkers in frontotemporal lobar degeneration: Current status and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

Neuroproteomics tools in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

What is frontotemporal dementia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

From frontotemporal lobar degeneration pathology to frontotemporal lobar degeneration biomarkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

The role of proteomics in dementia and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

Systems approach to neurodegenerative disease biomarker discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

Proteomics of human neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

Biomarker discovery in neurodegenerative diseases: a proteomic approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

Biological and methodical challenges of blood-based proteomics in the field of neurological research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

Proteomic analysis of lymphoblastoid cells from Nasu-Hakola patients: a step forward in our understanding of this neurodegenerative disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

Salivary proteomics and biomarkers in neurology and psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

Antibody-based proteomics for human tissue profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

Dementia of frontal lobe type: neuropathology and immunohistochemistry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

Increased S100beta in the cerebrospinal fluid of patients with frontotemporal dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

S100 beta protein expression in Alzheimer disease: potential role in the pathogenesis of neuritic plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

Serum biomarker for progranulin-associated frontotemporal lobar degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

Progranulin protein levels are differently regulated in plasma and CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

Plasma levels of progranulin and interleukin-6 in frontotemporal lobar degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

The genetics and neuropathology of frontotemporal lobar degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

TDP-43 as a possible biomarker for frontotemporal lobar degeneration: a systematic review of existing antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

Nuclear import impairment causes cytoplasmic trans-activation response DNA-binding protein accumulation and is associated with frontotemporal lobar degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

Rules for nuclear localization sequence recognition by karyopherin beta 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

Fused in sarcoma (FUS) interacts with the cytolinker protein plectin: implications for FUS subcellular localization and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

Identification of CSF biomarkers for frontotemporal dementia using SELDI-TOF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

Amyloid beta1-40 quantification in CSF: comparison between chromatographic and immunochemical methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

Optimization protocol for amyloid-β peptides detection in human cerebrospinal fluid using SELDI TOF MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

Basics and recent advances of two dimensional- polyacrylamide gel electrophoresis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

State of the art of 2D DIGE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

Phylogenetic diversity of the expression of the microtubule-associated protein tau: implications for neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

Aberrantly regulated proteins in frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

Astrocytic neuroprotection through induction of cytoprotective molecules; a proteomic analysis of mutant P301S tau-transgenic mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

Studies of the pathophysiological mechanisms in frontotemporal dementia by proteome analysis of CSF proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

Oxidative modification of proteins in the frontal cortex of Alzheimer's disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

Asparaginyl endopeptidase cleaves TDP-43 in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

Proteomics analysis reveals novel components in the detergent-insoluble subproteome in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

Proteomic analysis of hippocampal dentate granule cells in frontotemporal lobar degeneration: application of laser capture technology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

Aberrant septin 11 is associated with sporadic frontotemporal lobar degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

Proteomic analysis identifies dysfunction in cellular transport, energy, and protein metabolism in different brain regions of atypical frontotemporal lobar degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

Stable isotopic labeling in proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

Quantitative analysis of the detergent-insoluble brain proteome in frontotemporal lobar degeneration using SILAC internal standards

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

CSF amyloid-β 1-38 and 1-42 in FTD and AD: Biomarker performance critically depends on the detergent accessible fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500090

21 January 2018

Identifiers

DOI

10.1002/PRCA.201500090

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27061321%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

1 reference